(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD proposed) (NP (NP (DT a) (JJ convolutional) (JJ neural) (NN network) (NN model)) (PP (IN for) (NP (NN gender) (NN prediction))) (VP (VBG using) (NP (JJ English) (NNP Twitter) (NN text)) (PP (IN as) (NP (NN input)))))) (. .))
(S (NP (NP (NN Ensemble)) (PP (IN of) (NP (VBN proposed) (NN model)))) (VP (VP (VBD achieved) (NP (NP (DT an) (NN accuracy)) (PP (IN at) (NP (CD 0.8237))) (PP (IN on) (NP (NN gender) (NN prediction))))) (CC and) (VP (VBN compared) (ADVP (RB favorably)) (PP (IN with) (NP (NP (DT the) (JJ state-of-the-art) (NN performance)) (PP (IN in) (NP (DT a) (JJ recent) (NN author) (VBG profiling) (NN task))))))) (. .))
(S (NP (PRP We)) (ADVP (RB further)) (VP (VP (VBD leveraged) (NP (DT the) (JJ trained) (NNS models)) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN gender) (NNS labels)) (PP (IN from) (NP (DT an) (ADJP (NNP HPV) (NN vaccine) (VBN related)) (NN corpus)))))))) (CC and) (VP (VBD identified) (NP (NP (NN gender) (NN difference)) (PP (IN in) (NP (NP (JJ public) (NNS perceptions)) (VP (VBG regarding) (NP (NNP HPV) (NN vaccine)))))))) (. .))
(S (NP (DT The) (NNS findings)) (VP (VBP are) (ADJP (RB largely) (JJ consistent) (PP (IN with) (NP (JJ previous) (JJ survey-based) (NNS studies))))) (. .))
